Join
Live feed
·
INSIDERFilingvia Quantisnow
Galectin Therapeutics Inc. logo

Director Shlevin Harold H. exercised 20,000 shares at a strike of $1.98 and sold $172,424 worth of shares (24,499 units at $7.04), decreasing direct ownership by 42% to 6,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GALT (Galectin Therapeutics Inc.) and more on Quantisnow.